Sort   by:  
 Page size 
UnknownVE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis.
Not available
S-EPMC7936662 | biostudies-literature
UnknownCalcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants.
Not available
S-EPMC10485742 | biostudies-literature
UnknownReconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig.
Not available
S-EPMC7002414 | biostudies-literature
UnknownCancer therapy shapes the fitness landscape of clonal hematopoiesis.
Not available
S-EPMC7891089 | biostudies-literature
UnknownAlcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program).
Not available
S-EPMC6734183 | biostudies-literature
UnknownDiscovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.
Not available
S-EPMC7343592 | biostudies-literature
UnknownCommon, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Not available
S-EPMC8661833 | biostudies-literature
UnknownImpact of postoperative acute kidney injury in patients undergoing major gastrointestinal surgery on 1-year survival and renal outcomes: a national multicentre cohort study.
Not available
S-EPMC8759520 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
Sort   by:  
 Page size